Health Tech BJC-St. Luke’s Merger Will Be ‘the First of Many’ M&A Deals in the Hospital Sector This Year By Katie Adams
BioPharma, Pharma Bristol Myers Squibb Makes Another M&A Move, Striking $4B Deal for RayzeBio By Frank Vinluan
BioPharma, Pharma AstraZeneca’s Icosavax M&A Deal Helps It Stand Out in Multivalent Vaccines Chase By Frank Vinluan
BioPharma, Pharma Still Hungry for New Obesity Meds, Novo Nordisk Makes Another M&A Deal By Frank Vinluan
BioPharma, Pharma Danaher Continues M&A Streak, Buying Life Sciences Firm Abcam for $5.7B By Frank Vinluan
BioPharma, Startups VC Report: Biotech Financings Fall, M&A Activity Expected to Pick Up By Frank Vinluan
Health Tech Healthcare M&A Activity Reaches 3-Year Low, But It Might Pick Up in the Back Half of ‘23 By Katie Adams
